🧵How much PFA is enough?
*⃣A new @hrs_journal systematic review evaluated the balance between efficacy and safety across currently available single-shot PFA systems, focusing on the impact of dosing (number of applications). #EPeeps@HRSonline
➡️Review Process:
• 804 PubMed records screened → 47 studies included (23 efficacy, 26 safety)
• CE/FDA-approved single-shot PFA platforms only
• Endpoints: acute PVI, freedom from atrial arrhythmia, hemolysis/AKI, and myocardial injury
🤔The central question: Does delivering more PFA improve outcomes—or simply increase collateral injury?
https://t.co/RUjYIfAwGJ